Clinical Trial

Study on the Treatment of Dental Implants Using the AmbiJet System for Peri-implantitis and Peri-implant Mucositis

Study acronym: AmbiJet-FIH
Recruiting
View on ClinicalTrials.gov →
Summary
Inflammation of the tissue surrounding a dental implant (peri-implantitis or peri-implant mucositis) can lead to implant loss in advanced stages. The AmbiJet system utilizes cold atmospheric plasma (CAP), a physical procedure with a strong antibacterial effect. This clinical trial investigates whether the additional application of cold plasma directly on the patient following conventional mechanical cleaning of the implants is safe, well-tolerated, and resolves inflammation more quickly compared to standard treatment.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-07-25
Trial Details
NCT Number NCT07722715
Lead Sponsor Freiburger Medizintechnik GmbH
Conditions Peri Implant Mucositis, Peri Implantitis
Enrollment 26 participants
Start Date 2026-02-14
Primary Completion 2026-11 (estimated)
Study Completion 2026-11-20 (estimated)
Updated on ClinicalTrials.gov 2026-07-24